|
Number
|
COMPETENCYThe student should be able to
|
Domain K/S/A/C
|
Level K/KH/ SH/P
|
Core Y/N
|
Suggested Teaching learning method
|
Suggested Assessment method
|
Number required to certify
|
Vertical Integration
|
Horizontal Integration
|
|
GENERAL MEDICINE (CODE: IM)
|
|
Topic: Heart Failure, Number of competencies: (30), Number of procedures that require certification : (01)
|
|
IM1.1
|
Describe and discuss the epidemiology, pathogenesis clinical evolution and course of common causes of heart disease including: rheumatic/ valvular, ischemic, hypertrophic
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pathology, Physiology
|
|
|
inflammatory
|
|
IM1.2
|
Describe and discuss the genetic basis of some forms of heart failure
|
K
|
KH
|
N
|
Lecture, Small group
|
Written
|
|
Pathology, Physiology
|
|
|
discussion
|
|
IM1.3
|
Describe and discuss the aetiology microbiology pathogenies and clinical evolution of rheumatic fever, criteria, degree of rheumatic activity and rheumatic valvular heart disease and its complications including
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pathology, Physiology, Microbiology
|
|
|
infective endocarditis
|
|
IM1.4
|
Stage heart failure
|
K
|
KH
|
Y
|
Lecture, Small
|
Written/ Viva voce
|
|
Pathology, Physiology
|
|
|
group discussion
|
|
IM1.5
|
Describe, discuss and differentiate the processes involved in R Vs L heart failure, systolic vs diastolic
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pathology, Physiology
|
|
|
failure
|
|
IM1.6
|
Describe and discuss the compensatory mechanisms involved in heart failure including cardiac remodelling and
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pathology, Physiology
|
|
|
neurohormonal adaptations
|
|
IM1.7
|
Enumerate, describe and discuss the factors that exacerbate heart failure including ischemia, arrythmias, anemia,
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pathology, Physiology
|
|
|
thyrotoxicosis, dietary factors drugs etc.
|
|
IM1.8
|
Describe and discuss the pathogenesis and development of common arrythmias involved in heart failure particularly atrial
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pathology, Physiology
|
|
|
fibrillation
|
|
IM1.9
|
Describe and discuss the clinical presentation and features, diagnosis, recognition and management of acute
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pathology, Microbiology
|
|
|
rheumatic fever
|
|
IM1.19
|
Enumerate the indications for and describe the findings of heart failure with the following conditions including: 2D echocardiography, brain natriuretic peptide, exercise testing, nuclear medicine testing and coronary
|
S
|
KH
|
N
|
Lecture, Small group discussion, Bedside clinic
|
Skill assessment
|
|
Radio- diagnosis
|
|
|
angiogram
|
|
IM1.22
|
Assist and demonstrate the proper technique in collecting specimen for
|
S
|
SH
|
Y
|
DOAP
|
Skill assessment
|
|
Microbiology
|
|
|
blood culture
|
session
|
|
IM1.24
|
Describe and discuss the pharmacology of drugs including indications, contraindications in the management of heart failure including diuretics, ACE inhibitors, Beta blockers,
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Viva voce/written
|
|
Pharmacology
|
|
|
aldosterone antagonists and cardiac glycosides
|
|
IM1.27
|
Describe and discuss the role of penicillin prophylaxis in the
|
K
|
KH
|
Y
|
Bedside clinic, Small
|
Written
|
|
Microbiology, Pharmacology
|
|
|
prevention of rheumatic heart disease
|
group discussion
|
|
IM1.30
|
Administer an intramuscular injection with
|
S
|
SH
|
Y
|
Bedside clinic, Skill assessment
|
Log book documentati
|
|
Pharmacology
|
|
|
an appropriate explanation to the patient
|
on of completion
|
|
Topic: Acute Myocardial Infarction / IHD, Number of competencies: (24), Number of procedures that require certification : (02)
|
|
IM2.1
|
Discuss and describe the epidemiology, antecedents and risk factors for atherosclerosis and
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pathology, Physiology, Community Medicine
|
|
|
ischemic heart disease
|
|
IM2.2
|
Discuss the aetiology of risk factors both modifiable and
|
K
|
KH
|
Y
|
Lecture, Small
|
Written/ Viva voce
|
|
Pathology, Physiology
|
|
|
non modifiable of atherosclerosis and IHD
|
group discussion
|
|
IM2.3
|
Discuss and describe the lipid cycle and the role of dyslipidemia in the pathogenesis of
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Physiology, Biochemistry
|
|
|
atherosclerosis
|
|
IM2.4
|
Discuss and describe the pathogenesis natural history, evolution and complications of
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pathology, Physiology
|
|
|
atherosclerosis and IHD
|
|
IM2.5
|
Define the various acute coronary syndromes and describe their evolution, natural history and
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pathology
|
|
|
outcomes
|
|
IM2.12
|
Choose and interpret a lipid profile and identify the desirable lipid profile in the
|
S
|
SH
|
Y
|
Bedside clinic, DOAP
|
Skill assessment
|
|
Biochemistry
|
|
|
clinical context
|
session
|
|
IM2.15
|
Discuss and describe the medications used in patients with an acute coronary
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pharmacology
|
|
|
syndrome based on the clinical presentation
|
|
IM2.18
|
Discuss and describe the indications, formulations, doses, side effects and monitoring for drugs used in the management of
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pharmacology, Biochemistry
|
|
|
dyslipidemia
|
|
IM2.20
|
Discuss and describe the assessment and relief of pain in acute coronary
|
K
|
KH
|
Y
|
Lecture, Small group
|
Written/ Viva voce
|
|
Pharmacology
|
|
|
syndromes
|
discussion
|
|
IM2.23
|
Describe and discuss the indications for nitrates, antiplatelet agents, gpIIb IIIa inhibitors, beta blockers, ACE inhibitors etc in the management of
|
K
|
KH
|
Y
|
Lecture, Small group discussion
|
Written/ Viva voce
|
|
Pharmacology
|
|
|
coronary syndromes
|
|
IM2.24
|
Counsel and communicate to patients with empathy lifestyle changes in atherosclerosis / post
|
C/A
|
SH
|
Y
|
DOAP
|
Skill assessment
|
|
AETCOM
|
|
|
coronary syndromes
|
session
|
|
IM3.1
|
Define, discuss, describe and distinguish community acquired pneumonia, nosocomial pneumonia and
|
K
|
K
|
Y
|
Lecture, Small group discussion
|
Short note/ Viva voce
|
|
Human Anatomy, Pathology, Microbiology
|
|
|
aspiration pneumonia
|
|
IM3.2
|
Discuss and describe the aetiologies of various kinds of pneumonia and their microbiology depending on
|
K
|
K
|
Y
|
Lecture, Small group discussion
|
Short note/ Viva voce
|
|
Microbiology
|
|
|
the setting and immune status of the host
|
|
IM3.3
|
Discuss and describe the pathogenesis, presentation,
|
K
|
K
|
Y
|
Lecture, Small
|
Short note/ Viva voce
|
|
Pathology, Microbiology
|
|
|
natural history and complications of pneumonia
|
group discussion
|
|
IM3.7
|
Order and interpret diagnostic tests based on the clinical presentation including: CBC, Chest X ray PA view, Mantoux, sputum gram stain, sputum culture and sensitivity, pleural fluid examination
|
S
|
SH
|
Y
|
Bedside clinic, DOAP
|
Skill assessment
|
|
Radio- diagnosis, Microbiology
|
|
|
and culture, HIV testing and ABG
|
session
|
|
IM3.10
|
Demonstrate the correct technique in a mannequin
|
S
|
SH
|
Y
|
DOAP
|
Skill assessment
|
|
Microbiology
|
|
|
and interpret results of a blood culture
|
session
|
|
IM3.11
|
Describe and enumerate the indications for further testing including HRCT, Viral cultures, PCR and
|
S
|
SH
|
Y
|
Bedside clinic, DOAP
|
Skill assessment
|
|
Radiodiagnosis
|
|
|
specialised testing
|
session
|
, Microbiology
|
|
IM3.12
|
Select, describe and prescribe based on the most likely aetiology, an appropriate empirical antimicrobial based on the pharmacology and
|
S
|
SH
|
Y
|
Bed side clinic, DOAP
|
Skill Assessment/ Written/ Viva voce
|
|
Pharmacology, Microbiology
|
|
|
antimicrobial spectrum
|
session
|
|
IM3.13
|
Select, describe and prescribe based on culture and sensitivity appropriate empaling antimicrobial
|
S
|
SH
|
Y
|
Bedside clinic, DOAP
|
Skill assessment/ Written/ Viva voce
|
|
Pharmacology, Microbiology
|
|
|
based on the pharmacology and antimicrobial spectrum.
|
session
|
|
IM3.14
|
Perform and interpret a
|
S
|
P
|
Y
|
DOAP
|
Skill
|
|
Microbiology
|
|
|
sputum gram stain and AFB
|
session
|
assessment
|
